Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues - PubMed (original) (raw)
Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues
P M Cannon et al. J Virol. 1994 Aug.
Abstract
Sequence comparisons of the integrase (IN) proteins from different retroviruses have identified several highly conserved residues. We have introduced mutations at 16 of these sites into the integrase gene of human immunodeficiency virus type 1 and analyzed the phenotypes of the resulting viruses. The viruses were all normal for p24 content and reverse transcriptase activity. In addition, all of the mutants could infect T-cell lines and undergo reverse transcription, as assessed by PCR analysis. Most of the mutant viruses also had normal Western blot (immunoblot) profiles, although three of the mutations resulted in reduced signals for IN relative to the wild type on the immunoblots and mutation of residue W235 completely abolished recognition of the protein by pooled sera from human immunodeficiency virus type 1-positive patients. Mutations that have previously been shown to abolish activity in in vitro studies produced noninfectious viruses. The substitution of W235 was notable in producing a noninfectious virus, despite previous reports of this residue being nonessential for IN activity in vitro (A.D. Leavitt, L. Shiue, and H.E. Varmus, J. Biol. Chem. 268:2113-2119, 1993). In addition, we have identified four highly conserved residues that can be mutated without any affect on viral replication in T-cell lines.
Similar articles
- Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
Masuda T, Planelles V, Krogstad P, Chen IS. Masuda T, et al. J Virol. 1995 Nov;69(11):6687-96. doi: 10.1128/JVI.69.11.6687-6696.1995. J Virol. 1995. PMID: 7474078 Free PMC article. - Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration.
Taddeo B, Haseltine WA, Farnet CM. Taddeo B, et al. J Virol. 1994 Dec;68(12):8401-5. doi: 10.1128/JVI.68.12.8401-8405.1994. J Virol. 1994. PMID: 7966634 Free PMC article. - Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.
Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R. Engelman A, et al. J Virol. 1995 May;69(5):2729-36. doi: 10.1128/JVI.69.5.2729-2736.1995. J Virol. 1995. PMID: 7535863 Free PMC article. - Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection.
Leavitt AD, Robles G, Alesandro N, Varmus HE. Leavitt AD, et al. J Virol. 1996 Feb;70(2):721-8. doi: 10.1128/JVI.70.2.721-728.1996. J Virol. 1996. PMID: 8551608 Free PMC article.
Cited by
- Oligomeric HIV-1 Integrase Structures Reveal Functional Plasticity for Intasome Assembly and RNA Binding.
Jing T, Shan Z, Dinh T, Biswas A, Jang S, Greenwood J, Li M, Zhang Z, Gray G, Shin HJ, Zhou B, Passos D, Aiyer S, Li Z, Craigie R, Engelman AN, Kvaratskhelia M, Lyumkis D. Jing T, et al. bioRxiv [Preprint]. 2024 Jan 27:2024.01.26.577436. doi: 10.1101/2024.01.26.577436. bioRxiv. 2024. PMID: 38328132 Free PMC article. Preprint. - Multimodal Functionalities of HIV-1 Integrase.
Engelman AN, Kvaratskhelia M. Engelman AN, et al. Viruses. 2022 Apr 28;14(5):926. doi: 10.3390/v14050926. Viruses. 2022. PMID: 35632668 Free PMC article. Review. - Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1+ and TIGIT+ CD4 T Cells.
Llewellyn GN, Seclén E, Wietgrefe S, Liu S, Chateau M, Pei H, Perkey K, Marsden MD, Hinkley SJ, Paschon DE, Holmes MC, Zack JA, Louie SG, Haase AT, Cannon PM. Llewellyn GN, et al. J Virol. 2019 May 1;93(10):e02086-18. doi: 10.1128/JVI.02086-18. Print 2019 May 15. J Virol. 2019. PMID: 30842333 Free PMC article. - HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency.
Llewellyn GN, Alvarez-Carbonell D, Chateau M, Karn J, Cannon PM. Llewellyn GN, et al. J Neurovirol. 2018 Apr;24(2):192-203. doi: 10.1007/s13365-017-0604-2. Epub 2017 Dec 18. J Neurovirol. 2018. PMID: 29256041 Free PMC article. - Tuning DNA binding affinity and cleavage specificity of an engineered gene-targeting nuclease via surface display, flow cytometry and cellular analyses.
Niyonzima N, Lambert AR, Werther R, De Silva Feelixge H, Roychoudhury P, Greninger AL, Stone D, Stoddard BL, Jerome KR. Niyonzima N, et al. Protein Eng Des Sel. 2017 Jul 1;30(7):503-522. doi: 10.1093/protein/gzx037. Protein Eng Des Sel. 2017. PMID: 28873986 Free PMC article.
References
- Mol Cell Biol. 1982 Sep;2(9):1044-51 - PubMed
- EMBO J. 1993 Aug;12(8):3261-7 - PubMed
- Proc Natl Acad Sci U S A. 1986 Oct;83(20):7648-52 - PubMed
- Mol Cell Biol. 1987 Jan;7(1):379-87 - PubMed
- J Virol. 1988 Nov;62(11):3958-64 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources